Indian activists take part in a protest rally against the killing of Indian journalist Gauri Lankesh at the India Gate memorial in New Delhi on September 6th, 2017.
Scientists have studied the potential for ketamine to treat severe depression for years, but this is the first time the FDA has indicated its use as an antidepressant.